Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching

Frontiers in Medicine

Wei Xu¹  Ling Fei¹  ChenLu Huang¹  WeiXia Li¹  XuDong Xie¹  Liang Chen²  Qiang Li² 

[1] Department of Liver Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China;null;

关键词: severe acute respiratory syndrome coronavirus 2;    coronavirus disease 2019;    Thymosin alpha 1;    Thymosin-α1;    efficacy evaluation;   

DOI  :  10.3389/fmed.2021.664776

来源: Frontiers

【 授权许可】

CC BY